**Core Concept**
Type II hypercholesterolemia, also known as familial hypercholesterolemia, is a genetic disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol in the blood. This condition is primarily caused by mutations in the LDL receptor gene, leading to impaired clearance of LDL cholesterol from the bloodstream.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of Type II hypercholesterolemia. In this condition, the LDL receptor is defective or absent, resulting in reduced uptake of LDL cholesterol by the liver. This impairment leads to increased levels of LDL cholesterol in the blood, which can cause premature atherosclerosis and cardiovascular disease. The LDL receptor plays a crucial role in removing excess cholesterol from the bloodstream by binding to apolipoprotein B-100 (ApoB-100) on the surface of LDL particles.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Type II hypercholesterolemia is not primarily caused by overproduction of very-low-density lipoprotein (VLDL) cholesterol. While VLDL is a precursor to LDL, the primary defect in Type II hypercholesterolemia lies in the LDL receptor, not in VLDL production.
* **Option B:** This option is incorrect because Type II hypercholesterolemia is not caused by a deficiency of apolipoprotein A-I (ApoA-I), which is a component of high-density lipoprotein (HDL) cholesterol. ApoA-I is involved in reverse cholesterol transport, not in the clearance of LDL cholesterol.
* **Option C:** This option is incorrect because Type II hypercholesterolemia is not primarily caused by increased activity of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. While this enzyme is indeed important in cholesterol metabolism, the primary defect in Type II hypercholesterolemia lies in the LDL receptor, not in cholesterol synthesis.

**Clinical Pearl / High-Yield Fact**
Type II hypercholesterolemia is often associated with premature cardiovascular disease, and early diagnosis and treatment are critical to prevent long-term complications. Patients with this condition may require aggressive lipid-lowering therapy, including statins, ezetimibe, and bile acid sequestrants.

**Correct Answer:** C. Defective LDL receptor.